Pharma-Bio Serv (PBSV) Operating Expenses (2010 - 2026)

Pharma-Bio Serv's Operating Expenses history runs 16 years deep, the most recent figure standing at $757365.0 for Q2 2026.

• Operating Expenses for Q2 2026 came in at $757365.0, down 17.41% year-over-year; the trailing twelve-month figure through Apr 2026 was $3.3 million (down 9.0% YoY), and the FY2025 annual result was $3.5 million, down 6.73% from the prior year.
• Operating Expenses came in at $757365.0 for Q2 2026 at Pharma-Bio Serv, down from $816909.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.1 million in Q3 2023 to a low of $757365.0 in Q2 2026.
• A 5-year average of $921172.0 and a median of $924449.0 in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses plunged 85.08% in 2022 and climbed 15.56% in 2023, its largest moves.
• Over 5 years, Operating Expenses stood at $939683.0 in 2022, then increased by 4.46% to $981570.0 in 2023, then slipped by 10.28% to $880700.0 in 2024, then climbed by 0.17% to $882207.0 in 2025, then decreased by 14.15% to $757365.0 in 2026.
• The last three Operating Expenses figures came in at $757365.0 (Q2 2026), $816909.0 (Q1 2026), and $882207.0 (Q4 2025), per Business Quant data.